Article

A Network-Based Discovery of Prognostic Markers in Recurrent IDH wild-type Gliomas

2025-07-20

Abstract excerpt

<h4>Background</h4> Isocitrate dehydrogenase wild-type (IDH wild-type) gliomas represents the most aggressive subtype of diffuse gliomas, characterized by therapeutic resistance and dismal prognosis. Despite advances in molecular classification, reliable prognostic biomarkers for these tumors remain limited, particularly for recurrent disease. This study aims to identify gene expression signatures associated with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 06ce32c2-7440-5537-a3a0-e209cd866b78
DOI: 10.1101/2025.07.17.665414

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Network-Based Discovery of Prognostic Markers in Recurrent IDH wild-type GliomasDOI 10.1101/2025.07.17.665414Read

A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas.Semantic proximity Read

A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.Semantic proximity Read

Construction and Validation of a Recurrence Prediction Model of Glioblastoma and Exploration of Its Biological FunctionsSemantic proximity Read

Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaSemantic proximity Read

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.Semantic proximity Read

Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors.Semantic proximity Read

Whole exome sequencing reveals the genetic heterogeneity and evolutionary history of primary gliomas and matched recurrencesSemantic proximity Read

Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.Semantic proximity Read

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct PrognosesSemantic proximity Read

Molecular classification of IDH-mutant glioblastomas based on gene expression profilesSemantic proximity Read

Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways.Semantic proximity Read

LUNAR: A Deep Learning Model to Predict Glioma Recurrence Using Integrated Genomic and Clinical DataSemantic proximity Read